<DOC>
	<DOC>NCT02254824</DOC>
	<brief_summary>The purpose of EMINENT study is to evaluate the efficacy of Xuezhikang or atorvastatin in hypertensive patients at low/moderate cardiovascular risk.</brief_summary>
	<brief_title>Effects and Underlying Mechanism of Lipid Lowering Intervention on Vascular Protection in Hypertensive Patients</brief_title>
	<detailed_description>EMINENT study is to evaluate the efficacy of Xuezhikang or atorvastatin on vascular function protection in hypertensive patients at low/moderate cardiovascular risk.</detailed_description>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>All patients must meet the hypertension with low or moderate cardiovascular risk following 2010 Guidelines for prevention and treatment of hypertension in China Secondary Hypertension Women who are pregnant or lactating History of mental instability, or major psychiatric illness not adequately controlled and stable on therapy Type 2 Diabetes Active liver disease or impaired liver function tests Impaired renal function Uncontrolled cardiac arrhythmia Patient who is unable to give informed consent Any condition or situation, which in the opinion of the investigator, might pose a risk to the patient or confound the results of the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Xuezhikang</keyword>
	<keyword>atorvastatin</keyword>
</DOC>